Bruce D Hammock is affiliated with the UC Davis Comprehensive Cancer Center.[1]He specializes in entomology.[1]
He co-discovered the soluble epoxide hydrolase, and many of his more than 1100 publications and patents are on the P450 branch of the arachidonate cascade where the soluble epoxide hydrolase degrades natural analgesic and anti-inflammatory compounds.[2]He is the founding director of the UC Davis NIEHS Superfund Research Program and is a founding member of the UC Davis Comprehensive Cancer Center.[2]A member of the UC Davis faculty since 1980, Hammock received his bachelor of science degree magna cum laude from Louisiana State University in entomology and chemistry, and his doctorate from UC Berkeley in entomology and toxicology, working in xenobiotic metabolism.[3]He is a fellow of the Entomological Society of America and recipient of the ESA's Recognition Award for Insect Physiology, Biochemistry and Toxicology.[4]He was featured in the January 2015 edition of Chemical Research in Toxicology and in the Sept. 4, 2014 edition of Newsweek.[5]The Hammock laboratory has published almost 900 peer-reviewed papers on the sEH enzyme, discovered while Hammock and Sarjeet Gill were researching insect developmental biology and green insecticides at UC Berkeley.[6]
Events - Primer's event detection algorithm clusters and summarizes multiple documents describing real-world events.
Mentions - Mentions are snippets of text that map to a person.
Docs - The number of documents that match to a person in Primer's corpus of news articles.
Full tech explainer here.
Remember to check the sources and follow Wikipedia's guidelines.
University of California, Davis
6
335
51
Bruce Hammock, UC Davis distinguished professor, is the recipient of a RIVER Program award. The award is part of the Revolutionizing Innovative, Visionary Environmental Health Research Program of the National Institutes of Environmental Health. “I am thrilled to receive the RIVER award,” said Hammock, who joined the UC Davis faculty in 1980 and now devotes much of his research toward environmental health.[7]
07/27/2020
The National Institute on Drug Abuse has awarded a grant to EicOsis LLC as part of the to support human clinical trials of a novel compound that has been found effective for the treatment of pain in preclinical animal studies. Dr. Bruce Hammock, EicOsis CEO and founder, and his team aim to provide a new analgesic solution for neuropathic pain management without the side effects of standard pain therapies.[9]
10/15/2019